Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours

MLA

Jacques Machecourt, et al. “Cost Effectiveness of Thrombolytic Treatment for Myocardial Infarction: Comparison of Anistreplase, Alteplase and Streptokinase in 270 Patients Treated within 4 Hours.” European Heart Journal, vol. 14, no. 1, Jan. 1993. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0d0450070cf8bfd3fb3a01eacbe3614d&authtype=sso&custid=ns315887.

APA

Jacques Machecourt, T. Henon, L Foroni, Gérald Vanzetto, Jean Pierre Bassand, J. Cassagnes, J Calop, M. P. Terisse, B. Denis, & J Dumoulin. (1993). Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours. European Heart Journal, 14(1).

Chicago

Jacques Machecourt, T. Henon, L Foroni, Gérald Vanzetto, Jean Pierre Bassand, J. Cassagnes, J Calop, M. P. Terisse, B. Denis, and J Dumoulin. 1993. “Cost Effectiveness of Thrombolytic Treatment for Myocardial Infarction: Comparison of Anistreplase, Alteplase and Streptokinase in 270 Patients Treated within 4 Hours.” European Heart Journal 14 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0d0450070cf8bfd3fb3a01eacbe3614d&authtype=sso&custid=ns315887.